Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Pharmaceutical is a Chinese pharmaceutical company primarily engaged in the research, development, manufacture, and sale of chemical raw materials and finished medicine. The company is well-known for its production of analgesics and antipyretics, particularly aspirin and paracetamol, serving both domestic and international markets. Its product portfolio spans various therapeutic areas including cardiovascular health, pain management, and anti-infectives. Jilin Pharmaceutical operates large-scale manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards, positioning it as a significant supplier of bulk drug substances. The company has historically been a key player in the industrial landscape of Jilin Province, contributing to the regional biotech and healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Pharma.